About Kempenhaeghe
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2
Eisai Inc.
1
Epilepsiecentrum Kempenhaeghe
1
LivaNova
1
Maastricht University Medical Center
1
Zogenix, Inc.
1
Clinical Trials at Kempenhaeghe
During the past decade, Kempenhaeghe conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment Study
2010-10-01
2013-12-01
Completed
47
Does VNS Interact With the Serotonergic and Immune System in Children With Intractable Epilepsy?
2006-03-01
2013-03-01
Unknown status
45
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
2016-07-05
2023-01-27
Completed
373
A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome
2017-01-27
2018-06-05
Completed
87
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
2018-02-05
2027-03-31
Active, not recruiting
2,000
A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
2019-04-22
2025-07-09
Active, not recruiting
412
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kempenhaeghe" #1 sponsor was "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 2 trials, followed by "Eisai Inc." with 1 trials
sponsored, "Epilepsiecentrum Kempenhaeghe" with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "Maastricht University Medical Center"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kempenhaeghe"
#1 collaborator was "Epilepsiecentrum Kempenhaeghe" with 1 trials as a collaborator, "Maastricht University Medical Center" with 1 trials as a collaborator and "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kempenhaeghe
According to Clinical.Site data, the most researched conditions in "Kempenhaeghe" are
"Dravet Syndrome" (3 trials), "Drug Resistant Epilepsy" (1 trials), "Electrical Status Epilepticus During Slow Wave Sleep" (1 trials), "Epilepsy" (1 trials) and "Epileptic Encephalopathy" (1 trials). Many other conditions were trialed in "Kempenhaeghe" in a lesser frequency.
Clinical Trials Intervention Types at Kempenhaeghe
Most popular intervention types in "Kempenhaeghe" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "ZX008 (Fenfluramine Hydrochloride)" (3 trials), "Matching Placebo" (1 trials), "Perampanel" (1 trials), "Vagus Nerve Stimulation (VNS) Therapy" (1 trials) and "Vagus Nerve Stimulator: Neurocybernetic prothesis NCP, Cyberonics Inc., Webster, TX, USA" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kempenhaeghe
The vast majority of trials in "Kempenhaeghe" are
7 trials for "All" genders.
Clinical Trials Status at Kempenhaeghe
Currently, there are NaN active trials in "Kempenhaeghe".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kempenhaeghe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kempenhaeghe, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".